摘要
心血管疾病已成为全世界的"头号杀手",并仍持续增长,其中大约有一半的病例发生在亚太地区。而且与西方国家相比,亚洲地区的心血管疾病患者更趋年轻化。因此,对心血管的防治战线必须前移。
Cardiovascular disease has become the world's No.1 killer,and still growing,with about half of the cases occurred in the Asia Pacific region.And compared with the western countries,the patients with cardiovascular diseases in Asia tend to be younger.Therefore,the front for the prevention and treatment of cardiovascular diseases in Asia should be moved forward.
出处
《中国处方药》
2010年第10期28-30,共3页
Journal of China Prescription Drug